Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
Volume: 394, Issue: 5, Pages: 997 - 1001
Published: Jan 8, 2021
Abstract
Chloroquine and hydroxychloroquine belong to the aminoquinoline drugs. Studies revealed that chloroquine and hydroxychloroquine shows antagonism activity against COVID-19 under laboratory conditions. ARDS and ALI are conditions that occur in patients with COVID-19 as the main pathological complications of cytokine storm. Inflammasomes play a key role in the pathogenesis of many diseases associated with destructive inflammation. NLRP3...
Paper Details
Title
Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
Published Date
Jan 8, 2021
Volume
394
Issue
5
Pages
997 - 1001
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History